Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004274 · ClinicalTrials.gov registry record · NA

Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome

A NA study of Turner's Syndrome, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
NA
Development phase
260
Enrollment target
1
Study location

NCT00004274 is a NA study of Turner's Syndrome that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 260 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004274, a NA study of Turner's Syndrome, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
NA
Development phase
260 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Turner's syndrome is a disease in which females are missing all or part of one X chromosome and do not produce estrogen. Giving estrogen is standard treatment for girls who have Turner's syndrome. Estrogen may be effective treatment for mental and social functioning problems experienced by girls with Turner's syndrome. PURPOSE: Clinical trial to study the effectiveness of long term estrogen therapy on mental and social functioning in girls who have Turner's syndrome.

Conditions Studied

Interventions

  • DRUG Estrogen

Study Locations (1)

Pennsylvania

  • Jefferson Medical College of Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 1990-02
Phase NA

What the Registry Record Tells You About NCT00004274

The ClinicalTrials.gov registry entry for NCT00004274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Turner's Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Estrogen is the first listed.

NCT00004274 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00004274 about?

NCT00004274 is a clinical study titled "Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome". RATIONALE: Turner's syndrome is a disease in which females are missing all or part of one X chromosome and do not produce estrogen. Giving estrogen is standard treatment for girls who have Turner's syndrome. Estrogen may be effective treatment for mental and social functioning problems experienced b...

What is the current status of trial NCT00004274?

This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 1990-02.

What conditions does trial NCT00004274 study?

This clinical trial studies the following conditions: Turner's Syndrome.

What interventions are being tested in trial NCT00004274?

The interventions under investigation include: Estrogen (DRUG).

Who is sponsoring clinical trial NCT00004274?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004274 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Turner's Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.